Rituximab-Based Chemoimmunotherapy Prolongs Survival of Patients With Chronic Lymphocytic Leukemia Independently of the Time of Administration
Titel:
Rituximab-Based Chemoimmunotherapy Prolongs Survival of Patients With Chronic Lymphocytic Leukemia Independently of the Time of Administration
Auteur:
Delgado, Julio Ghita, Gabriela Baumann, Tycho Santacruz, Rodrigo Dlouhy, Ivan Aymerich, Marta Rozman, Maria Creus, Natalia Pereira, Arturo Montserrat, Emili